Lv11
30 积分 2025-01-25 加入
Indirect comparative efficacy and safety of tirzepatide vs semaglutide for the treatment of obesity or overweight in patients without type 2 diabetes
1小时前
待确认
Weight Loss Threshold and Inflection Points for Biochemical Remission of Male Obesity-Associated Secondary Hypogonadism After Sleeve Gastrectomy
1小时前
已完结
Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: a prospective cohort study
19天前
已完结
Epidemiology and determinants of obesity in China
4个月前
已完结
Liver steatosis and fibrosis in China
4个月前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990-2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
4个月前
已完结
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis
4个月前
已完结
Bariatric Surgery and Incident Development of Obesity-Related Comorbidities
4个月前
已完结
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
4个月前
已完结
The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis
4个月前
已完结
皖公网安备34019202002308
